Inhibition of cell cycle progression and apoptotic activity of resveratrol in human intrahepatic cholangiocarcinoma cell lines

1. deGroen PC, Gores GJ, LaRusso NF, Gunderson LL, Nagorney DM. Biliary tract cancers. N Engl J Med. 1999; 341:1368-78.10.1056/NEJM199910283411807Search in Google Scholar

2. Vatanasapt V, Martin N, Sriplung H, Chindavijak K, Sontipong S, Sriamporn H, et al. Cancer incidence in Thailand, 1988-1991. Cancer Epidemiol Biomarkers Prev. 1995; 4:475-83.Search in Google Scholar

3. Patel T. Cholangiocarcinoma. Nat Clin Pract Gastroenterol Hepatol. 2006; 3:33-42.10.1038/ncpgasthep0389Open DOISearch in Google Scholar

4. West J, Wood H, Logan RFA, Quinn M, Aithal GP. Trends in the incidence of primary liver and biliary tract cancers in England and Wales 1971-2001. Br J Cancer. 2006; 94:1751-8.10.1038/sj.bjc.6603127Search in Google Scholar

5. Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD. Cholangiocarcinoma. Lancet. 2005; 366:1303-14.10.1016/S0140-6736(05)67530-7Search in Google Scholar

6. Gusman J, Malonne H, Atassi G. A reappraisal of the potential chemopreventive and chemotherapeutic properties of resveratrol. Carcinogenesis. 2001; 22: 1111-7.10.1093/carcin/22.8.1111Open DOISearch in Google Scholar

7. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CWW, et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science. 1997; 275:218-20.10.1126/science.275.5297.218Search in Google Scholar

8. Pozo-Guisado E, Alvarez-Barrientos A, Mulero-Navarro S, Santiago-Josefat B, Fernandez-Salguero PM. The antiproliferative activity of resveratrol results in apoptosis in MCF-7 but not in MDA-MB-231 human breast cancer cells: cell specific alteration of the cell cycle. Biochem Pharmacol. 2002; 64:1375-86.10.1016/S0006-2952(02)01296-0Search in Google Scholar

9. Clement MV, Hirpara JL, Chawdhury SH, Pervaiz S. Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signalingdependent apoptosis in human tumor cells. Blood. 1998; 92:996-1002.10.1182/blood.V92.3.996Search in Google Scholar

10. Kim YA, Choi BT, Lee YT, Park DI, Rhee SH, Park KY, et al. Resveratrol inhibits cell proliferation and induces apoptosis of human breast carcinoma MCF-7 cells. Oncol Rep. 2004; 11:441-6.10.3892/or.11.2.441Search in Google Scholar

11. Park JW, Choi YJ, Jang MA, Lee YS, Jun DY, Suh SI, et al. Chemopreventive agent resveratrol, a natural product derived from grapes, reversibly inhibits progression through S and G2 phases of the cell cycle in U 937 cells. Cancer Lett. 2001; 163:43-9.10.1016/S0304-3835(00)00658-3Search in Google Scholar

12. Roncoroni L, Elli L, Dolfini E, Erba E, Dogliotti E, Terrani C, et al. Resveratrol inhibits cell growth in a human cholangiocarcinoma cell line. Liver International. 2008; 28:1426-36.10.1111/j.1478-3231.2008.01749.xOpen DOISearch in Google Scholar

13. Tepsiri N, Chaturat L, Sripa B, Namwat W, Wongkham S, Bhudhisawasdi V, et al. Drug sensitivity and drug resistance profiles of human intrahepatic cholangiocarcinoma cell lines. World J Gastroenterol. 2005; 11: 2748-53.10.3748/wjg.v11.i18.2748Open DOISearch in Google Scholar

14. Sripa B, Leungwattanawanit S, Nitta T, Wongkham C, Bhudhisawasdi V, Puapairoj A, et al. Establishment and characterization of an opisthorchiasis-associated cholangiocarcinoma cell line (KKU-100). World J Gastroenterol. 2005; 11:3392-7.10.3748/wjg.v11.i22.3392Open DOISearch in Google Scholar

15. Pinmai K, Chunlaratthanabhorn S, Ngamkitidechakul C, Soonthornchareon N, Hahnvajanawong C. Synergistic growth inhibitory effects of Phyllanthus emblica and Terminalia bellerica extracts with conventional cytotoxic agents: Doxorubicin and cisplatin against human hepatocellular carcinoma and lung cancer cells. World J Gastroenterol. 2008; 14: 1491-7.10.3748/wjg.14.1491Open DOISearch in Google Scholar

16. Hahnvajanawong C, Boonyanugomol W, Nasomyon T, Loilome W, Namwat N, Anantachoke N, et al. Apoptotic activity of caged xanthones from Garcinia hanburyi in cholangiocarcinoma cell lines. World J Gastroenterol. 2010; 16:2235-43.10.3748/wjg.v16.i18.2235Open DOISearch in Google Scholar

17. Nomura M, Nomura N, Newcomb EW, Lukyanov Y, Tamasdan C, Zagzag D. Geldanamycin induces mitotic catastrophe and subsequent apoptosis in human glioma cells. J Cell Physiol. 2004; 201:374-84.10.1002/jcp.20090Search in Google Scholar

18. Ribble D, Goldstein NB, Norris DA, Shellman YG. A simple technique for quantifying apoptosis in 96-well plates. BMC biotechnol. 2005; 5:12.10.1186/1472-6750-5-12Open DOISearch in Google Scholar

19. Herrmann M, Lorenz HM, VolI R, Grunke M, Woith W, Kalden JR. A rapid and simple method for the isolation of apoptotic DNA fragments. Nucleic Acids Res. 1994; 22:5506-7.10.1093/nar/22.24.5506Open DOISearch in Google Scholar

20. Niles RM, McFarland M, Weimer MB, Redkar A, Fu YM, Meadows GG. Resveratrol is a potent inducer of apoptosis in human melanoma cells. Cancer Lett. 2003; 190:157-63.10.1016/S0304-3835(02)00676-6Open DOISearch in Google Scholar

21. Compton MM. A biochemical hallmark of apoptosis: internucleosomal degradation of the genome. Cancer Metastasis Rev. 1992; 11:105-19.10.1007/BF000480581327565Open DOISearch in Google Scholar

22. Benitez DA, Pozo-Guisado E, Alvarez-Barrientos A, Fernandez-Salguero PM, Castellon EA. Mechanisms involved in resveratrol-induced apoptosis and cell cycle arrest in prostate cancer-derived cell lines. J Androl. 2007; 28:282-93.10.2164/jandrol.106.000968Open DOISearch in Google Scholar

23. Knuth A, Gabbert H, Dippold W, Klein O, Sachsse W, Bitter-Suermann D, et al. Biliary adenocarcinoma characterisation of three new human tumor cell lines. J Hepatol. 1985; 1:579-96.10.1016/S0168-8278(85)80002-7Open DOISearch in Google Scholar

24. Kim YA, Lee WH, Choi TH, Rhee SH, Park KY, Choi YH. Involvement of p21WAF1/CIP1, pRB, Bax and NF-κB in induction of growth arrest and apoptosis by resveratrol in human lung carcinoma A 549 cells. Int J Oncol. 2003; 23:1143-9.10.3892/ijo.23.4.1143Search in Google Scholar

25. Delmas D, Jannin B, Malki MC, Latruffe N. Inhibitory effect of resveratrol on the proliferation of human and rat hepatic derived cell lines. Oncol Rep. 2000; 7: 847-52.10.3892/or.7.4.847Search in Google Scholar

26. Larrosa M, Tomas-Barberan FA, Espin JC. Grape polyphenol resveratrol and the related molecule 4-hydroxystilbene induce growth inhibition, apoptosis, S-phase arrest, and upregulation of cyclins A, E, and B1 in human SK-Mel-28 melanoma cells. J Agric Food Chem. 2003; 51:4576-84.10.1021/jf030073cSearch in Google Scholar

27. Cooper GM, Hausman RE. The Cell: A Molecular Approach. 3rd ed. Washington DC: ASM Press; 2004.Search in Google Scholar

28. Harper JW, Elledge SJ, Keyomarsi K, Dynlacht B, Tsai LH, Zhang P, et al. Inhibition of cyclin-dependent kinases by p21. Mol Biol Cell. 1995; 6:387-400.10.1091/mbc.6.4.387Open DOISearch in Google Scholar

29. Gartel AL, Tyner AL. The role of the cyclin-dependent kinase inhibitor p21 in apoptosis. Mol Cancer Ther. 2002; 1:639-49.Search in Google Scholar

30. Kim YA, Rhee SH, Park KY, Choi YH. Antiproliferative effect of resveratrol in human prostate carcinoma cells. J Med Food. 2003; 6:273-80.10.1089/109662003772519813Open DOISearch in Google Scholar

31. Delmas D, Passilly-Degrace P, Jannin B, Malki MC, Latruffe N. Resveratrol, a chemopreventive agent, disrupts the cell cycle control of human SW480 colorectal tumor cells. Int J Mol Med. 2002; 10:193-9.10.3892/ijmm.10.2.193Search in Google Scholar

32. Jin P, Hardy S, Morgan DO. Nuclear localization of cyclin B1 controls mitotic entry after DNA damage. J Cell Biol. 1998; 141:875-85.10.1083/jcb.141.4.875Search in Google Scholar

33. Surh YJ, Hurh YJ, Kang JY, Lee E, Kong G, Lee SJ. Resveratrol, an antioxidant present in red wine, induces apoptosis in human promyelocytic leukemia (HL-60) cells. Cancer Lett. 1999; 140:1-10.10.1016/S0304-3835(99)00039-7Open DOISearch in Google Scholar

34. Bras M, Queenan B, Susin SA. Programmed cell death via mitochondria: different modes of dying. Biochemistry (Mosc). 2005; 70:231-9.10.1007/s10541-005-0105-4Search in Google Scholar

35. Cande C, Cecconi F, Dessen P, Kroemer G. Apoptosisinducing factor (AIF): key to the conserved caspaseindependent pathways of cell death ? J Cell Sci. 2002; 115:4727-34.10.1242/jcs.00210Open DOISearch in Google Scholar

36. Shin S, Sung BJ, Cho YS, Kim HJ, Ha NC, Hwang JI, et al. An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and-7. Biochemistry. 2001; 40:1117-23.10.1021/bi001603qSearch in Google Scholar

37. Park JW, Choi YJ, Suh SI, Baek WK, Suh MH, Jin IN, et al. Bcl-2 overexpression attenuates resveratrolinduced apoptosis in U937 cells by inhibition of caspase-3 activity. Carcinogenesis. 2001; 22:1633-9.10.1093/carcin/22.10.1633Search in Google Scholar

38. Vitrac X, Desmouliere A, Brouillaud B, Krisa S, Deffieux G, Barthe N, et al. Distribution of [14C]-trans-resveratrol, a cancer chemopreventive polyphenol, in mouse tissues after oral administration. Life Sci. 2003; 72: 2219-33.10.1016/S0024-3205(03)00096-1Open DOISearch in Google Scholar

39. Athar M, Back JH, Tang X, Kim KH, Kopelovich L, Bickers DR, et al. Resveratrol: A review of preclinical studies for human cancer prevention. Toxicol Appl Pharm. 2007; 224:274-83.10.1016/j.taap.2006.12.025208312317306316Search in Google Scholar

40. Frampton GA, Lazcano EA, Li H, Mohamad A, DeMorrow S. Resveratrol enhances the sensitivity of cholangiocarcinoma to chemotherapeutic agents. Lab Invest. 2010; 90:1325-38.10.1038/labinvest.2010.99292155420458282Open DOISearch in Google Scholar

41. Brown VA, Patel KR, Viskaduraki M, Crowell JA, Perloff M, Booth TD, et al. Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axis. Cancer Res. 2010; 70:9003-11.10.1158/0008-5472.CAN-10-2364298288420935227Open DOISearch in Google Scholar

42. Baur JA, Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov. 2006; 5:493-506. 10.1038/nrd206016732220Open DOISearch in Google Scholar